3860 — EPS Creative Health Technology Cashflow Statement
0.000.00%
- HK$261.09m
- HK$173.92m
- HK$544.52m
- 37
- 68
- 16
- 33
Annual cashflow statement for EPS Creative Health Technology, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.
2021 March 31st | R2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 7.14 | -22.7 | -48.2 | -24.1 | 33.4 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -0.232 | 5.14 | 5.61 | -10 | -39.2 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -22.3 | 18 | -0.034 | -8.49 | -27.9 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -12.4 | 4.02 | -38.1 | -28.6 | -17.9 |
Capital Expenditures | -0.525 | -0.283 | -2.41 | -5.04 | -5.71 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.291 | 4.63 | -8.97 | -15.4 | 62.9 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.234 | 4.35 | -11.4 | -20.4 | 57.2 |
Financing Cash Flow Items | -0.136 | 115 | -24.7 | 29.7 | -31.3 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -1.81 | 112 | -27.8 | 33.7 | -16.8 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -14.3 | 123 | -76.7 | -15.9 | 20.2 |